MedTrace Logo

Efficacy of Oral Tofacitinib in Combination of Narrow Band UVB in Treatment of Vitiligo

NCT07044141 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2025-06-29

No results posted yet for this study

Summary

20 patients will be enrolled. All were given narrowband UVB . 10 wil be give oral azathriopfine . 10 will be given tofacitinib

Conditions

  • Vitiligo

Interventions

DRUG

Azathioprine

azathioprine 50mg twice daily will be given

DRUG

Tofacitinib

It is a janus kinase inhibitor

Sponsors & Collaborators

  • Lahore General Hospital

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-01
Primary Completion
2025-09-30
Completion
2025-09-30

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07044141 on ClinicalTrials.gov